112 related articles for article (PubMed ID: 9084808)
21. Efficacy and safety of once-daily combination therapy with didanosine, lamivudine and nevirapine in antiretroviral-naive HIV-infected patients.
Ribera E; Rodríguez-Pardo D; Rubio M; Soler A; Pedrol E; Blanco JL; González A; Crespo M; Falcó V; Ocaña I; Deig E; Miró JM; Pahissa A
Antivir Ther; 2005; 10(5):605-14. PubMed ID: 16152754
[TBL] [Abstract][Full Text] [Related]
22. Quantification of HIV in semen: correlation with antiviral treatment and immune status.
Vernazza PL; Gilliam BL; Dyer J; Fiscus SA; Eron JJ; Frank AC; Cohen MS
AIDS; 1997 Jul; 11(8):987-93. PubMed ID: 9223732
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.
AIDS; 1999 Apr; 13(5):565-73. PubMed ID: 10203381
[TBL] [Abstract][Full Text] [Related]
24. Pediatric antiretroviral therapy: from research to practice.
Farley J; Vink P
Pediatr AIDS HIV Infect; 1996 Feb; 7(1):9-13. PubMed ID: 11361479
[No Abstract] [Full Text] [Related]
25. [The male genital tract: A host for HIV].
Le Tortorec A; Dejucq-Rainsford N
Gynecol Obstet Fertil; 2007 Dec; 35(12):1245-50. PubMed ID: 18035579
[TBL] [Abstract][Full Text] [Related]
26. Viramune triple combo reduces viral load below limit of detection.
AIDS Patient Care STDS; 1997 Dec; 11(6):456. PubMed ID: 11361870
[No Abstract] [Full Text] [Related]
27. Two studies suggest nevirapine benefit for children.
AIDS Patient Care STDS; 1997 Jun; 11(3):195. PubMed ID: 11361798
[No Abstract] [Full Text] [Related]
28. Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine.
Foli A; Maserati R; Minoli L; Wainberg MA; Gallo RC; Lisziewicz J; Lori F
AIDS; 1998 Jun; 12(9):1113-4. PubMed ID: 9662215
[No Abstract] [Full Text] [Related]
29. Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
van't Wout AB; Ran LJ; de Jong MD; Bakker M; van Leeuwen R; Notermans DW; Loeliger AE; de Wolf F; Danner SA; Reiss P; Boucher CA; Lange JM; Schuitemaker H
J Clin Invest; 1997 Nov; 100(9):2325-32. PubMed ID: 9410911
[TBL] [Abstract][Full Text] [Related]
30. Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.
Celum CL; Buchbinder SP; Donnell D; Douglas JM; Mayer K; Koblin B; Marmor M; Bozeman S; Grant RM; Flores J; Sheppard HW
J Infect Dis; 2001 Jan; 183(1):23-35. PubMed ID: 11106536
[TBL] [Abstract][Full Text] [Related]
31. Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection.
Sei S; Sandelli SL; Theofan G; Ratto-Kim S; Kumagai M; Loomis-Price LD; Cox JH; Jarosinski P; Walsek CM; Brouwers P; Venzon DJ; Xu J; Pizzo PA; Moss RB; Robb ML; Wood LV
J Infect Dis; 1999 Sep; 180(3):626-40. PubMed ID: 10438349
[TBL] [Abstract][Full Text] [Related]
32. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
Saifee S; Joelson D; Braude J; Shrestha R; Johnson M; Sellers M; Galambos MR; Rubin RA
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1167-9. PubMed ID: 18639498
[TBL] [Abstract][Full Text] [Related]
33. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.
Marcelin AG; Tubiana R; Lambert-Niclot S; Lefebvre G; Dominguez S; Bonmarchand M; Vauthier-Brouzes D; Marguet F; Mousset-Simeon N; Peytavin G; Poirot C
AIDS; 2008 Aug; 22(13):1677-9. PubMed ID: 18670231
[TBL] [Abstract][Full Text] [Related]
34. Potential for the transmission of HIV-1 despite highly active antiretroviral therapy.
Haase AT; Schacker TW
N Engl J Med; 1998 Dec; 339(25):1846-8. PubMed ID: 9854123
[No Abstract] [Full Text] [Related]
35. HIV-1 in semen: an isolated virus reservoir.
Byrn RA; Zhang D; Eyre R; McGowan K; Kiessling AA
Lancet; 1997 Oct; 350(9085):1141. PubMed ID: 9343504
[No Abstract] [Full Text] [Related]
36. Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission.
Krieger JN; Coombs RW; Collier AC; Ho DD; Ross SO; Zeh JE; Corey L
J Urol; 1995 Sep; 154(3):1035-40. PubMed ID: 7637049
[TBL] [Abstract][Full Text] [Related]
37. Early treatment of HIV infection.
Fessel WJ
N Engl J Med; 1995 Dec; 333(26):1782; author reply 1783. PubMed ID: 7491153
[No Abstract] [Full Text] [Related]
38. In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine.
Delforge ML; Liesnard C; Debaisieux L; Tchetcheroff M; Farber CM; Van Vooren JP
AIDS; 1995 Jan; 9(1):89-90. PubMed ID: 7893446
[No Abstract] [Full Text] [Related]
39. Effect of antiretroviral therapy on HIV shedding in semen.
Barroso PF; Schechter M; Gupta P; Melo MF; Vieira M; Murta FC; Souza Y; Harrison LH
Ann Intern Med; 2000 Aug; 133(4):280-4. PubMed ID: 10929169
[TBL] [Abstract][Full Text] [Related]
40. Effect of antiviral treatment on the shedding of HIV-1 in semen.
Vernazza PL; Gilliam BL; Flepp M; Dyer JR; Frank AC; Fiscus SA; Cohen MS; Eron JJ
AIDS; 1997 Aug; 11(10):1249-54. PubMed ID: 9256943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
